MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · IEX Real-Time Price · USD
27.21
-0.68 (-2.44%)
At close:
May 31, 2023, 4:00 PM
27.07
-0.14 (-0.51%)
After-hours:
May 31, 2023, 7:39 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 |
|---|---|---|---|
| Selling, General & Admin | 23.01 | 18.04 | 0.11 |
| Research & Development | 42.05 | 35.53 | 0 |
| Other Operating Expenses | 0 | 0 | 0 |
| Operating Expenses | 65.06 | 53.58 | 0.11 |
| Operating Income | -65.06 | -53.58 | -0.11 |
| Other Expense / Income | -0.59 | 0.06 | -0.01 |
| Pretax Income | -64.47 | -53.64 | -0.09 |
| Income Tax | 0.04 | 0 | 0 |
| Net Income | -64.51 | -53.64 | -0.09 |
| Shares Outstanding (Basic) | 29 | 233 | 9 |
| Shares Outstanding (Diluted) | 29 | 233 | 9 |
| Shares Change | -87.40% | 2510.73% | - |
| EPS (Basic) | -1.70 | -230.15 | -0.01 |
| EPS (Diluted) | -1.70 | -230.15 | -0.01 |
| Free Cash Flow Per Share | -1.90 | -0.15 | -0.04 |
| EBITDA | -64.46 | -53.63 | -0.09 |
| Depreciation & Amortization | 0.01 | 0 | 0 |
| EBIT | -64.47 | -53.64 | -0.09 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).